Application of antibody CD29 in identification and sorting of human-placenta-chorion-avillosum-derived mesenchymal stem cells
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- CHENGDU QINGKE BIOTECH
- Publication Date
- 2020-12-11
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of identification of mesenchymal stem cells. Background technique
[0002] In the basic research or clinical research of biomedicine, when analyzing the cell number and function changes of a specific cell group, it is necessary to separate this group of cells from other cells. At this time, it is necessary to separate them according to different cell surface markers. separate. Cell surface markers refer to membrane proteins embedded in the lipid bilayer structure of cell membranes, including membrane antigens, membrane receptors and other molecules. CD molecules (Cluster of Differentiation, differentiation clusters or differentiation groups, also called leukocyte differentiation antigens) are One of the most commonly used cell surface markers refers to the application of monoclonal antibody identification-based methods to identify the same differentiation antigen recognized by monoclonal antibodies from dif...